ObsEva: ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals

(marketscreener.com) Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland - November 30, 2023 - ObsEva SA , a biopharmaceutical company developing novel therapies for women's health, today announced that, following a comprehensive assessment of the company's financial position, the Board of...https://www.marketscreener.com/quote/stock/OBSEVA-153872618/news/ObsEva-Announces-Application-for-a-Moratorium-to-Facilitate-Pivotal-Deals-45468365/?utm_medium=RSS&utm_content=20231130